Analytical Data
-
Gene name
Spondin-2/SPON2
- Application
-
Alternative Names
DIL1; Mindin; M-spondin; Extracellular Matrix Protein; Differentially expressed in cancerous and non-cancerous lung cells 1
-
Species
Rat
-
Source
E. coli
-
Tag
N-His
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q9WV75
-
Expression Region
Val119~Val330
-
Molecular Weight
33kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
Spondin-2 (SPON2) is a secreted glycoprotein belonging to the Spondin family, primarily involved in the regulation of cell adhesion and the modulation of interactions between extracellular matrices and cells. Research into SPON2 has gained momentum due to its potential implications in various biological processes and diseases, including tissue regeneration, inflammation, and neurological disorders. The protein is thought to play a crucial role in the central nervous system by influencing neuronal development and survival. Additionally, SPON2 has been implicated in the progression of certain cancers, possibly through its effects on cell migration and invasion. Given these diverse roles, generating recombinant SPON2 protein has become a focal point for researchers aiming to elucidate its functions, investigate its mechanisms of action, and explore its potential as a therapeutic target. By leveraging recombinant DNA technology, scientists can produce SPON2 in controlled environments, enabling detailed studies of its structure, interactions, and biological effects. Understanding the properties of SPON2 at the molecular level could offer insights into its utility in clinical applications and contribute to the development of novel therapeutic strategies for diseases associated with its dysregulation.
